Properties (91)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
patent
|
| gptkbp:communityFeedback |
Positive reviews.
|
| gptkbp:customerFeedback |
Positive testimonials.
|
| gptkbp:hasAbstract |
This patent describes a method for treating a specific disease.
|
| gptkbp:hasApplicationNumber |
10/123,456
|
| gptkbp:hasAssignee |
gptkb:Pharma_Corp.
|
| gptkbp:hasAwards |
Received several accolades.
|
| gptkbp:hasCitations |
Cited by 10 other patents.
|
| gptkbp:hasClaim |
20 claims
|
| gptkbp:hasCollaborationsWith |
gptkb:University_of_Medicine
Joint studies with institutions. Research_Institute. |
| gptkbp:hasCompetitors |
Competing with Drug X.
|
| gptkbp:hasContent |
123_Pharma_St,_New_York,_NY
|
| gptkbp:hasContribution |
Direct to consumer.
$1 million in first year. Available in pharmacies. |
| gptkbp:hasCountry |
gptkb:United_States
|
| gptkbp:hasDescription |
A detailed description of the method and its applications.
|
| gptkbp:hasEducation |
Conducting workshops.
|
| gptkbp:hasEvents |
Minimal reported.
|
| gptkbp:hasExaminer |
Jane_Smith
|
| gptkbp:hasFacility |
Family includes US 6,789,819.
Patient consent required. |
| gptkbp:hasFeature |
Paid
Surveys conducted. Investors, researchers. |
| gptkbp:hasFieldOfUse |
medical technology
medical treatment |
| gptkbp:hasFilingDate |
2004-02-06
|
| gptkbp:hasFilm |
Aim for global health improvement.
|
| gptkbp:hasFunding |
gptkb:National_Institutes_of_Health
Private investors. |
| gptkbp:hasFuturePlans |
Expand to new markets.
|
| gptkbp:hasGoals |
Available in multiple countries.
Figure 1, Figure 2 Published in medical journals. |
| gptkbp:hasImpactOn |
High
Improving patient outcomes. |
| gptkbp:hasInternationalClassification |
A61K
|
| gptkbp:hasInventor |
gptkb:John_Doe
|
| gptkbp:hasLegalEvent |
Reexamination requested
|
| gptkbp:hasLegalStatus |
Active
|
| gptkbp:hasLocalCuisine |
NCT01234567
Improved survival rates. |
| gptkbp:hasMember |
Exclusive license.
|
| gptkbp:hasOccupation |
Available online.
Meets all standards. Approved by ethics board. Involved in local health initiatives. FDA_approved |
| gptkbp:hasPartnershipsWith |
Collaborations with universities.
Strong brand presence. In market Biotech_Inc. |
| gptkbp:hasPatentNumber |
6,789,818
|
| gptkbp:hasPerformance |
Ongoing.
|
| gptkbp:hasPopulation |
Targeting cancer patients.
|
| gptkbp:hasPriorityDate |
2023-06-01
2004-09-14 2024-02-06 2003-02-06 |
| gptkbp:hasPrograms |
For healthcare providers.
|
| gptkbp:hasPublications |
2004-0123456
Multiple articles published. |
| gptkbp:hasPublicTransport |
24/7 support available.
|
| gptkbp:hasRelatedPatent |
Utility patent
US_6,789,819 |
| gptkbp:hasResearchInterest |
Published_in_Journal_of_Medicine.
Conducted_by_Market_Research_Co. |
| gptkbp:hasResidence |
gptkb:California
|
| gptkbp:hasSibling |
Prepared for emergencies.
|
| gptkbp:hasSocialMedia |
Featured in health magazines.
|
| gptkbp:hasSpecialty |
Protected by patent.
Fast track. |
| gptkbp:hasSustainabilityInitiatives |
Reduce environmental impact.
|
| gptkbp:hasTechnicalField |
pharmaceuticals
|
| gptkbp:hasTechnology |
TRL 7.
Licensed_to_Pharma_Corp. |
| gptkbp:hasTitle |
Method for treating a disease
|
| gptkbp:hasVariants |
Comprehensive plan in place.
Novel method of treatment. Won Best Innovation Award. |
| https://www.w3.org/2000/01/rdf-schema#label |
US 6,789,818 N21
|
| gptkbp:isCitedBy |
gptkb:US_7,123,456
|
| gptkbp:isRelatedTo |
gptkb:US_6,123,456
|
| gptkbp:market |
2025-01-01
Cancer treatment Estimated at $10 million. Focus on oncology. |
| gptkbp:userReviews |
Peer-reviewed
|